GlassScriptPhysician profile
Alap R Jani
NPI 1568749224
$4,496.62
in general payments reported to CMS, 2019-2025
40 companies · $656 in 2025
The $656 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $608 · 2020: $343 · 2021: $918 · 2022: $836 · 2023: $542 · 2024: $594 · 2025: $656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,791.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $861.36 | 2019-2025 | |
| Abbott Laboratories | $519.59 | 2019-2025 | Cardiomems, Pressurewire, Diamondback Peripheral |
| Janssen Pharmaceuticals, INC | $461.84 | 2019-2023 | Xarelto |
| Pfizer INC. | $322.05 | 2019-2025 | |
| Boston Scientific Corporation | $257.11 | 2022-2025 | Ranger, General - Vascular Intervention, Watchman Flx |
| Shockwave Medical, INC | $220.32 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $218.39 | 2019-2021 | |
| Amgen INC. | $203.29 | 2019-2025 | Repatha, Repatha |
| Philips North America LLC | $202.54 | 2019-2025 | Labosys, (Br7) Peripheral Specialty Balloon |
| Medtronic, INC. | $163.84 | 2021-2025 | Hawkone, Chocolate Pta Balloon Catheter, Closurefast |
| Biotronik INC. | $120.58 | 2019 | |
| Merck Sharp & Dohme LLC | $92.48 | 2021-2024 | Winrevair |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $78.01 | 2021-2023 | Lifevest |
| Amarin Pharma, INC. | $70.38 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $62.80 | 2020-2023 | Eliquis |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $53.31 | 2021-2024 | Lutonix Drug Coated Balloon |
| Endotronix, INC. | $52.79 | 2024-2025 | Cordella Pulomonary Artery Pressure Sensor |
| Acist Medical Systems, INC. | $46.35 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.80 | 2021 | |
| Cvrx, INC. | $43.32 | 2021-2022 | |
| Terumo Medical Corporation | $40.54 | 2020 | |
| Alnylam Pharmaceuticals INC. | $32.32 | 2025 | Amvuttra |
| Tactile Systems Technology INC | $28.43 | 2020-2024 | Entre Plus, Flexitouch Plus |
| Heartflow, INC. | $25.74 | 2025 | |
| Impulse Dynamics (USA) INC. | $24.59 | 2022 | |
| Novo Nordisk INC | $22.68 | 2025 | Ozempic |
| Lilly USA, LLC | $21.86 | 2025 | Zepbound |
| Angiodynamics, INC. | $20.57 | 2022 | |
| Surmodics, INC. | $19.92 | 2022 | |
| Cardiva Medical, INC. | $18.43 | 2024 | Cardiva Vascade 6/7f Vcs |
| Portola Pharmaceuticals, LLC | $18.16 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.14 | 2023 | Brilinta |
| Agepha Pharma Fz LLC | $16.49 | 2024 | Lodoco |
| Sanofi-Aventis U.S. LLC | $15.69 | 2023 | |
| Edwards Lifesciences Corporation | $15.53 | 2019 | |
| Cashflow Solutions, LLC | $15.27 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Teleflex LLC | $14.83 | 2021 | |
| Medtronic Vascular, INC. | $13.26 | 2019 | |
| Strongbridge US INC. | $11.22 | 2020 | |
| Cardiovascular Systems INC. | $9.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alap Jani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.